Home > Newsletters > FDAnews Drug Daily Bulletin > FDA: NECC Failed to Fix Problems After Early Warning Signs
FDAnews Drug Daily Bulletin
Oct. 30, 2012 | Vol. 9 No. 213
FDA: NECC Failed to Fix Problems After Early Warning Signs
The New England Compounding Center (NECC), at the heart of a nationwide fungal meningitis outbreak, dropped the ball after seeing early signs of unacceptable levels of microbial contamination, the FDA says. The NECC’s own environmental monitoring found mold and bacteria in multiple locations earlier this year, including on surfaces in clean rooms used to produce sterile steroid injections, an Oct. 1 to Oct. 26 inspection found.
Drug Industry Daily
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.